Understanding which pathway your body may respond to most favorably requires integrating genetic predisposition data, biomarker assessment, and clinical evidence
Even with this unprecedented incretin power, the extratumoral microenvironment, hyperinsulinemia-driven FAK/PYK2 activation and collagen remodeling in adipose, kidney, liver, and heart, remains untouched and continues to fuel residual progression in 5070 % of obesity, T2D, CKD & HFpEF patients
Too much of the conversation around weight loss still stops at the scale
GLP-1 receptor agonists and GLP-1 and glucose-dependent insulinotropic peptide agonists have several mechanisms of action, including reduction of gastric emptying, inhibition of glucagon secretion, beneficial changes in the intestinal microbiome, and direct effects on hypothalamic nuclei to enhance satiety (which promotes weight loss)
Trust and Transparency Noom is one of the most recognized names in digital weight loss
This is why at Real Peptides, we're uncompromising about our process
